Join
Zosano Pharma Corporation logo

ZSAN

NASDAQ

Zosano Pharma Corporation

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2015
$0.61+0.07 (+12.96%)
News25/Ratings1

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Latest news

25 items

ZSAN FAQ

7 questions
  • What does Zosano Pharma Corporation do?
    Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
  • Where does ZSAN stock trade?
    Zosano Pharma Corporation (ZSAN) is listed on NASDAQ.
  • What sector and industry is ZSAN in?
    Zosano Pharma Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Zosano Pharma Corporation go public?
    Zosano Pharma Corporation (ZSAN) completed its IPO in 2015.
  • What are analysts saying about ZSAN?
    Zosano Pharma Corporation has had 1 recent analyst action on file. The most recent action was from BTIG: Neutral on 2022-02-23.
  • What companies are similar to ZSAN?
    Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ZSAN side-by-side with any of them on Quantisnow.
  • How can I track ZSAN on Quantisnow?
    Quantisnow aggregates Zosano Pharma Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZSAN to receive live email and push alerts on every new disclosure.